If you are submitting this form due to interest in the news coverage around MSK’s rectal cancer immunotherapy trial, please note:
- This clinical trial is for patients with Stage II or III locally advanced cancers, whose tumors have a particular genetic makeup known as mismatch repair deficient (MMRd) or microsatellite instability (MSI).
- Patients who don’t know whether they have this specific kind of tumor should ask their doctor to get their tumor tested.
After filling out this form, you can expect to hear from one of our care advisors within three to four business days.
To speak with someone about your patient, you can also call 212-639-4900, Mon–Fri, 9:00 a.m.– (Eastern Time).